Document is current
Any future updates will be listed below
-
Authors
Menzl, Ingeborg https://orcid.org/0000-0003-3347-7772
Zhang, Tinghu
Berger-Becvar, Angelika
Grausenburger, Reinhard
Heller, Gerwin
Prchal-Murphy, Michaela
Edlinger, Leo
Knab, Vanessa M.
Uras, Iris Z.
Grundschober, Eva
Bauer, Karin
Roth, Mareike
Skucha, Anna
Liu, Yao
Hatcher, John M.
Liang, Yanke
Kwiatkowski, Nicholas P.
Fux, Daniela
Hoelbl-Kovacic, Andrea
Kubicek, Stefan https://orcid.org/0000-0003-0855-8343
Melo, Junia V.
Valent, Peter
Weichhart, Thomas https://orcid.org/0000-0002-4349-0797
Grebien, Florian https://orcid.org/0000-0003-4289-2281
Zuber, Johannes
Gray, Nathanael S. https://orcid.org/0000-0001-5354-7403
Sexl, Veronika
-
Funding
Funding for this research was provided by:
Austrian Science Fund (P27248-B28 to D.F.)
Austrian Science Fund (P28571-B21 to V.S.)
Austrian Science Fund (F4706-B20 to V.S.)
Austrian Science Fund (SFB6107 to V.S.)
Austrian Science Fund (F4704-B20 to P.V.)
- License Information
-
More Information
Article History
Received: 12 January 2019
Accepted: 20 September 2019
First Online: 18 October 2019
Competing interests
: N.S.G. is a founder, science advisory board member (SAB), and equity holder in Gatekeeper, Syros, Petra, C4, B2S, and Soltego. The Gray lab receives or has received research funding from Novartis, Takeda, Astellas, Taiho, Janssen, Kinogen, Voronoi, Her2llc, Deerfield, and Sanofi. N.P.K., N.S.G., T.Z., and Y.L. are inventors on the patent WO2017/185034 that covers degrader YKL-06-101. N.S.G. and J.M.H. are inventors on a patent that covers JH-XI-10-02. The remaining authors declare no competing interests.
